Buenos Aires cohort of men who have sex with men: Prevalence, incidence, risk factors, and molecular genotyping of HIV type 1

AIDS Research and Human Retroviruses

Volumn 23, Issue 11, 2007, Pages 1322-1329

  Segura, Marcela ^a   Estani, Sergio Sosa ^b   Marone, Rubén ^c   Bautista, Christian T ^d   Pando, María A ^a,e   Eyzaguirre, Lindsay ^e   Sánchez, José L ^f   Carr, Jean K ^e   Montano, Silvia M ^d   Weissenbacher, Mercedes ^a,g   Ávila, María M ^a,g  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^c Nexo Asociacion Civil   (Argentina)

^d California   (Peru)

^e INSTITUTE OF HUMAN VIROLOGY   (United States)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^g Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS RNA;

ADULT; AGED; ARGENTINA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; MALE; MALE HOMOSEXUAL; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SEXUAL BEHAVIOR; ADOLESCENT; CLASSIFICATION; COHORT ANALYSIS; DNA SEQUENCE; GENETICS; HOMOSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PHYLOGENY; PROSPECTIVE STUDY; VIROLOGY;

ADOLESCENT; ADULT; ARGENTINA; COHORT STUDIES; GENOTYPE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; PHYLOGENY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 38449114445     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0063     Document Type: Article

References (22)

1. Boletín sobre el SIDA en la República Argentina. Buenos Aires: Ministry of Health, National AIDS Program, December 2005. Available at http://www.msal.gov.ar/htm/site/sida/site/datos-epidboletines.asp.
2. Pando MA, Maulen S, Weissenbacher M, et al.: High human immunodeficiency virus type 1 seroprevalence in men who have sex with men in Buenos Aires, Argentina: Risk factors for infection. Int J Epidemiol 2003;32:735-740.
3. Russel KL, Carcamo C, Watts DM, et al.: Emerging genetic diversity of HIV-1 in South America. AIDS 2000;14:1785-1791.
4. Bongertz V, Bou-Habib DC, Brigido LFM, et al.: HIV diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV strains in three potential HIV vaccine evaluation sites. J Acquir Immune Defic Syndr 2000;23:184-193.
5. Carrion G, Hierholzer J, Montano S, et al.: Sequence note circulating recombinant form CRF02_AG in South America. AIDS Res Hum Retroviruses 2003;19:329-332.
6. Carr JK, Avila M, Gomez Carrillo M, et al.: Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001;15(15):F41-47.
7. De Sa Filho DJ, Sucupira MCA, Casiero MM, et al.: Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retroviruses 2006;22(1);1-13.
8. Avila MM, Pando MA, Carrion G, et al.: Two HIV-1 epidemics in Argentina: Different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 2002;29(4):422-426.
9. Espinosa A, Vignoles M, Gomez Carrillo M, et al.: Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. J Acquir Immune Defic Syndr 2004;36:630-635.
10. Buchbinder SP, Douglas JM, Mc Kirnan DJ, et al.: Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate. J Infect Dis 1996;174:954-961.
11. Suligoy B, Wagner TM, Ciccozzi M, et al.: The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: Objectives and methods of feasibility studies. Vaccine 2005;23:1437-1445.
12. Esparza J and Osmanov S: HIV vaccines: A global perspective. Curr Mol Med 2003;3:183-193.
13. Salminen MO, Koch C, Sanders-Buell E, et al.: Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology 1995;20;213(1):80-86.
14. Carr JK, Salminen MO, Koch C, et al.: Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996;70(9):5935-5943.
15. Salminen MO, Carr JK, Burke DS, et al.: Identification of breakpoints in intergenotypic recombinants of HIV-1 by bootscanning. AIDS Res Hum Retroviruses 1995;11(11):1423-1425.
16. Segura M, Sosa Estani S, Marone R, et al.: Buenos Aires cohort of men who have sex with men: Recruitment, retention and seroincidence of HIV and other sexually-transmitted infections. The 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July, 2005 (Poster MoPe10.2P05).
17. Vignoles M, Avila MM, Osimani ML, et al.: HIV seroincidence estimates among at-risk populations in Buenos Aires and Montevideo: Use of the serologic testing algorithm for recent HIV seroconversion (STARHS). J Acquir Immune Defic Syndr 2006;42(4):494-500.
18. Greco DB, Andrade JC, Greco M, et al.: Recruitment, adhesion and feasibility of long-term follow-up of volunteers in an HIV incidence cohort of homosexual and bisexual male in Belo Horizonte, Brasil in preparation for HIV vaccine trials. Project Horizonte.1994-2005. The 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July, 2005 (Poster WePe13.13P03).
19. Brown AE, Sadler KE, Tomkins SE, et al.: Recent trends in HIV and other STIs in the United Kingdom: Data to the end of 2002. Sex Transm Infect 2004;80:159-166.
20. Katz MH, Schwarcz SK, Kellogg TA, et al.: Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 2002;92:388-394.
21. Hurtado I, Alastrue I, Ferreros I, et al.: Trends in HIV testing, serial HIV prevalence and HIV incidence among people attending a Center for AIDS Prevention from 1988 to 2003. Sex Transm Infect 2007;83(1):23-28.
22. Viñoles J, Serra M, Russi J, et al.: Seroincidence and phylogeny of human inmunodeficiency virus infections in a cohort of commercial sex workers in Montevideo, Uruguay. Am J Trop Med Hyg 2005;72(4):495-500.